{ "cik": 1802768, "cik_padded": "0001802768", "entityName": "Royalty Pharma plc", "fiscal_years": [ { "accn": "0001802768-26-000003", "filed": "2026-02-11", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1227383000.0, "cash": 618696000.0, "eps_diluted": 1.78, "net_income": 770947000.0, "operating_cash_flow": 2489823000.0, "operating_income": 1559518000.0, "revenue": 2378193000.0, "stockholders_equity": 9714939000.0, "total_assets": 19620780000.0, "total_liabilities": 9905841000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0196503549842155, "net_margin": 0.3241734375637301, "operating_margin": 0.6557575436476349, "revenue_growth_yoy": 0.05063536634069278, "roa_avg2y": 0.040743964055117, "roa_period_end": 0.039292372678354275, "roe_avg2y": 0.07687443552361596, "roe_period_end": 0.0793568544280103 } }, { "accn": "0001802768-26-000003", "filed": "2026-02-11", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 229651000.0, "cash": 929026000.0, "eps_diluted": 1.91, "net_income": 858983000.0, "operating_cash_flow": 2768986000.0, "operating_income": 1292444000.0, "revenue": 2263576000.0, "stockholders_equity": 10342366000.0, "total_assets": 18222715000.0, "total_liabilities": 7880349000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7619483781564103, "net_margin": 0.37948052108698804, "operating_margin": 0.5709744227717558, "revenue_growth_yoy": -0.03863916478449846, "roa_avg2y": 0.04964564502846243, "roa_period_end": 0.04713803623664201, "roe_avg2y": 0.08410412767043846, "roe_period_end": 0.0830547864966295 } }, { "accn": "0001802768-26-000003", "filed": "2026-02-11", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 304759000.0, "cash": 477010000.0, "eps_diluted": 2.53, "net_income": 1134834000.0, "operating_cash_flow": 2987802000.0, "operating_income": 1492150000.0, "revenue": 2354554000.0, "stockholders_equity": 10084289000.0, "total_assets": 16381851000.0, "total_liabilities": 6297562000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6244924158758243, "net_margin": 0.4819740808662702, "operating_margin": 0.633729360210044, "revenue_growth_yoy": 0.052448691788674756, "roa_avg2y": 0.06837313829538064, "roa_period_end": 0.06927385678211821, "roe_avg2y": 0.11574233150984449, "roe_period_end": 0.11253485496101906 } }, { "accn": "0001802768-26-000003", "filed": "2026-02-11", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "cash": 1710751000.0, "eps_diluted": 0.1, "net_income": 42832000.0, "operating_cash_flow": 2143980000.0, "operating_income": 307065000.0, "revenue": 2237215000.0, "stockholders_equity": 9525373000.0, "total_assets": 16813466000.0, "total_liabilities": 7288093000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7651241583925374, "net_margin": 0.019145231906633916, "operating_margin": 0.13725323672512477, "revenue_growth_yoy": -0.02282107201557745, "roa_avg2y": 0.002495358852172214, "roa_period_end": 0.002547481881487136, "roe_avg2y": 0.004332171297564802, "roe_period_end": 0.00449662181208022 } }, { "accn": "0001802768-25-000010", "filed": "2025-02-12", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "cash": 1541048000.0, "eps_diluted": 1.49, "net_income": 619728000.0, "operating_cash_flow": 2017536000.0, "operating_income": 1430715000.0, "revenue": 2289463000.0, "stockholders_equity": 10248545000.0, "total_assets": 17515865000.0, "total_liabilities": 7267320000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7091074879409711, "net_margin": 0.27068705630971107, "operating_margin": 0.6249129162602759, "revenue_growth_yoy": 0.07873807985759203, "roa_avg2y": 0.03695880305405352, "roa_period_end": 0.03538095321013264, "roe_avg2y": 0.06152868594485007, "roe_period_end": 0.060469852061926836 } }, { "accn": "0001802768-24-000012", "filed": "2024-02-15", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "cash": 1008680000.0, "eps_diluted": 1.32, "net_income": 975040000.0, "operating_cash_flow": 2034629000.0, "operating_income": 1595399000.0, "revenue": 2122353000.0, "stockholders_equity": 9895815000.0, "total_assets": 16020286000.0, "total_liabilities": 6124471000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6188950581634762, "net_margin": 0.4594146214131202, "operating_margin": 0.7517123683006549, "roa_avg2y": 0.06849552519529117, "roa_period_end": 0.060862833534931896, "roe_avg2y": 0.12159688445396478, "roe_period_end": 0.09853054043552754 } }, { "accn": "0001802768-23-000007", "filed": "2023-02-15", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 4266000.0, "cash": 246199000.0, "net_income": 2348535000.0, "operating_cash_flow": 1667239000.0, "operating_income": 2623176000.0, "stockholders_equity": 6141438000.0, "total_assets": 12449895000.0, "total_liabilities": 6308457000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.027195422309889, "roa_period_end": 0.1886389403284124, "roe_avg2y": 0.43924463766223965, "roe_period_end": 0.3824079963031459 } }, { "accn": "0001802768-22-000011", "filed": "2022-02-15", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD" }, "fundamentals": { "buybacks": 0.0, "net_income": 1377729000.0, "operating_cash_flow": 1618317000.0, "operating_income": 1364446000.0, "revenue": 1794894000.0, "stockholders_equity": 4552079000.0 }, "period_end": "2018-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": 0.7675823753380423, "operating_margin": 0.7601819383205917, "roe_avg2y": 0.3057331243672071, "roe_period_end": 0.302659290403352 } }, { "accn": "0001802768-21-000006", "filed": "2021-02-24", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": 4460546000.0 }, "period_end": "2017-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001802768-26-000003", "filed": "2026-02-11", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001802768.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001802768.json" }, "ticker": "RPRX" }